chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Coronary arterial stent insertion, Coronary artery disease, Cough, Crepitations
Clinical narrative: Patient reports that he has also been more short of breath than usual.  Reports that he has been using 2 pillows instead of 1 due to his shortness of breath.  Patient reports that she has also had some cough.  Reports chills however, has not checked his temperature.  His home nurse came to visit him and noted that his lower extremity swelling has significantly worsened and that he had crackles
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Peripheral swelling
Clinical narrative: Patient reports that he has also been more short of breath than usual.  Reports that he has been using 2 pillows instead of 1 due to his shortness of breath.  Patient reports that she has also had some cough.  Reports chills however, has not checked his temperature.  His home nurse came to visit him and noted that his lower extremity swelling has significantly worsened and that he had crackles
Age: 82.0
Sex: M
Vaccine: RSV
Symptoms: Atrial fibrillation, Condition aggravated, Loss of consciousness, Supraventricular tachycardia
Clinical narrative: Pt was given the Abrysvo (RSV) vaccine 9/6/23 by a pharmacist who was doing an offsite RSV clinic. Pt had no immediate reaction to the vaccine but approximately 20-25 minutes later the patient was found passed out in the hallway. The ambulance was called and pt then became alert and oriented. Per the facility caregiver, pt has a history of atrial fibrillation and congestive heart failure. He was set to have an appt with his provider to follow up on this. Pt has had incidents like this in the past but I wanted to report this since I had given him the vaccine less than 30 minutes prior. Pt was taken to the hospital via ambulance since he was having runs of SVT with a. fib.
Age: 53.0
Sex: M
Vaccine: FLUC4, FLUC4
Symptoms: Arthralgia, Pain
Clinical narrative: Approximately 24 hours after receiving the flu vaccine I started experiencing very sharp pain in my left shoulder.   The pain is consistent and increases any time I try to move my arm up past my waist or sideways.   I've iced it for some relief, but the pain comes back.   I do not have any redness at the injection site and touching the injection site does not hurt.  It seems to be deep tisse or muscular in nature.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Cough, Fatigue, Oropharyngeal pain
Clinical narrative: Patient with history of type 2 diabetes. She was brought to the ED by EMS on 8/30/23 with a few days of sore throat, dry cough, body aches, fatigue, and weakness. In the ED, a COVID-19 test was done which resulted positive. Due to the degree of her weakness, the patient was admitted 8/30/23 - 8/31/23 for observation. Of note, the patient has received the primary COVID vaccine series and three boosters.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, SARS-CoV-2 test positive
Clinical narrative: Patient with history of type 2 diabetes. She was brought to the ED by EMS on 8/30/23 with a few days of sore throat, dry cough, body aches, fatigue, and weakness. In the ED, a COVID-19 test was done which resulted positive. Due to the degree of her weakness, the patient was admitted 8/30/23 - 8/31/23 for observation. Of note, the patient has received the primary COVID vaccine series and three boosters.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Aphasia, Asthenia, Ataxia, Confusional state, Fall
Clinical narrative: Ataxia, high fever, confusion, loss of speech, falling, weakness, shingles- at left forehead and left temple, V1 along the trigeminal nerve x 2 after vaccine.   She was seen in Emergency Room admitted for  1 day, seen by two board certified Neurologists who concur this was Vaccine related/caused.  Remains in rehab with speech therapy
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Immunisation reaction, Pyrexia
Clinical narrative: Ataxia, high fever, confusion, loss of speech, falling, weakness, shingles- at left forehead and left temple, V1 along the trigeminal nerve x 2 after vaccine.   She was seen in Emergency Room admitted for  1 day, seen by two board certified Neurologists who concur this was Vaccine related/caused.  Remains in rehab with speech therapy
Age: 30.0
Sex: M
Vaccine: COVID19-2
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: Patient received vaccine outside of window making the dose invalid (vaccine had been out of ultra-freeze for >10 weeks).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture negative, COVID-19, Condition aggravated, Continuous glucose monitoring, Dyspnoea
Clinical narrative: Discharge Provider:  DO  Primary Care Provider: DO Admission Date: 6/3/2023  Discharge Date: 6/6/2023 Clinical Narrative: Pleasant 60 y/o F was admitted for sepsis and respiratory failure d/t bilateral interstitial pneumonia.  She tested positive for COVID 19 and urinary antigens were negative.  No sputum culture was able to be collected during this admission.  Blood cultures were negative.  The patient was treated with Rocephin, Doxycycline, Remdesivir, and Solumedrol and improved more quickly than expected.  Her serial labs showed improvement.  She was off of supplemental oxygen the afternoon of 6/5/23, and her home oxygen evaluation on 6/6/23 still showed no supplemental oxygen needs at rest or with activity.     She was medically stable for discharge home on 6/6 to finish antibiotics and steroids at home.  She will have repeat CBC, BMP next Monday.  She will have a follow up CXR in 1 month.   COVID-19 virus infection Assessment & Plan Shortness of breath, headache, and sinus discomfort all improved.  Continue Solu-Medrol 40 mg q.12 hours and remdesivir. Patient has 1 dose of Remdesivir due tomorrow am, but is now on RA oxygen and feeling much better.   Ready for discharge Improved COVID labs Continue Decadron x 7 days and prn Mucinex after discharge today Monitor labs outpatient  Monitor glucose See home O2 with no supplemental oxygen needed.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Headache, Interstitial lung disease, Laboratory test, Metabolic function test
Clinical narrative: Discharge Provider:  DO  Primary Care Provider: DO Admission Date: 6/3/2023  Discharge Date: 6/6/2023 Clinical Narrative: Pleasant 60 y/o F was admitted for sepsis and respiratory failure d/t bilateral interstitial pneumonia.  She tested positive for COVID 19 and urinary antigens were negative.  No sputum culture was able to be collected during this admission.  Blood cultures were negative.  The patient was treated with Rocephin, Doxycycline, Remdesivir, and Solumedrol and improved more quickly than expected.  Her serial labs showed improvement.  She was off of supplemental oxygen the afternoon of 6/5/23, and her home oxygen evaluation on 6/6/23 still showed no supplemental oxygen needs at rest or with activity.     She was medically stable for discharge home on 6/6 to finish antibiotics and steroids at home.  She will have repeat CBC, BMP next Monday.  She will have a follow up CXR in 1 month.   COVID-19 virus infection Assessment & Plan Shortness of breath, headache, and sinus discomfort all improved.  Continue Solu-Medrol 40 mg q.12 hours and remdesivir. Patient has 1 dose of Remdesivir due tomorrow am, but is now on RA oxygen and feeling much better.   Ready for discharge Improved COVID labs Continue Decadron x 7 days and prn Mucinex after discharge today Monitor labs outpatient  Monitor glucose See home O2 with no supplemental oxygen needed.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Respiratory failure, SARS-CoV-2 test positive, Sepsis, Sinus disorder
Clinical narrative: Discharge Provider:  DO  Primary Care Provider: DO Admission Date: 6/3/2023  Discharge Date: 6/6/2023 Clinical Narrative: Pleasant 60 y/o F was admitted for sepsis and respiratory failure d/t bilateral interstitial pneumonia.  She tested positive for COVID 19 and urinary antigens were negative.  No sputum culture was able to be collected during this admission.  Blood cultures were negative.  The patient was treated with Rocephin, Doxycycline, Remdesivir, and Solumedrol and improved more quickly than expected.  Her serial labs showed improvement.  She was off of supplemental oxygen the afternoon of 6/5/23, and her home oxygen evaluation on 6/6/23 still showed no supplemental oxygen needs at rest or with activity.     She was medically stable for discharge home on 6/6 to finish antibiotics and steroids at home.  She will have repeat CBC, BMP next Monday.  She will have a follow up CXR in 1 month.   COVID-19 virus infection Assessment & Plan Shortness of breath, headache, and sinus discomfort all improved.  Continue Solu-Medrol 40 mg q.12 hours and remdesivir. Patient has 1 dose of Remdesivir due tomorrow am, but is now on RA oxygen and feeling much better.   Ready for discharge Improved COVID labs Continue Decadron x 7 days and prn Mucinex after discharge today Monitor labs outpatient  Monitor glucose See home O2 with no supplemental oxygen needed.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis normal
Clinical narrative: Discharge Provider:  DO  Primary Care Provider: DO Admission Date: 6/3/2023  Discharge Date: 6/6/2023 Clinical Narrative: Pleasant 60 y/o F was admitted for sepsis and respiratory failure d/t bilateral interstitial pneumonia.  She tested positive for COVID 19 and urinary antigens were negative.  No sputum culture was able to be collected during this admission.  Blood cultures were negative.  The patient was treated with Rocephin, Doxycycline, Remdesivir, and Solumedrol and improved more quickly than expected.  Her serial labs showed improvement.  She was off of supplemental oxygen the afternoon of 6/5/23, and her home oxygen evaluation on 6/6/23 still showed no supplemental oxygen needs at rest or with activity.     She was medically stable for discharge home on 6/6 to finish antibiotics and steroids at home.  She will have repeat CBC, BMP next Monday.  She will have a follow up CXR in 1 month.   COVID-19 virus infection Assessment & Plan Shortness of breath, headache, and sinus discomfort all improved.  Continue Solu-Medrol 40 mg q.12 hours and remdesivir. Patient has 1 dose of Remdesivir due tomorrow am, but is now on RA oxygen and feeling much better.   Ready for discharge Improved COVID labs Continue Decadron x 7 days and prn Mucinex after discharge today Monitor labs outpatient  Monitor glucose See home O2 with no supplemental oxygen needed.
Age: 28.0
Sex: F
Vaccine: DTAP
Symptoms: Dizziness, Nausea, Pallor, Retching
Clinical narrative: Within approximately 30 minutes from TDAP administration, at approximately 8:15 am, patient experienced lightheadedness, dizziness, nausea, dry heaving, appeared pale per coworkers. Patient work for the day, declined need for medical evaluation. Per patient, all symptoms appeared resolved by 12 pm on date of administration.
Age: 48.0
Sex: F
Vaccine: HEP
Symptoms: Lip swelling, Swelling face, Urticaria
Clinical narrative: Pt. waited 15 minutes after injection .Injection tolerated well.  Pt. returned to us about 45minutes later.  She was experiencing hives all over body.  EMS notified.  Benadryl 50 mg given by mouth.  Facial swelling and swelling of lips noted.  life saving crew arrived. Oxygen started at 2liters/minute.  Pt. transported to E.R.   Numerous phonecalls to pt. after this event were made without reaching her.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Feeling abnormal, Headache, Herpes zoster, Laboratory test
Clinical narrative: She got her vaccine, a few days later she started with redness in the white of her eyes, and they are still a little red and still watery.  She also had burning in her body and itching, and not feeling good.  The burning and itching was all over her body.  She did notifiy the doctor and went to see him, and went to the ER a few days after she saw her body as she could not get over the burning and itching and gave her a prescription for itching.  Her PCP did not say much and feels like she had an allergy to it.  She did not give her anything for her symptoms.  She got the itching pills from the ER.  She is still having the burning pain in her body.  She has a slight headache that she doesn't have to take anything for and checked her head for tumors and has an itchy scalp and a tad of a headache and pain in her neck and head.  She did not have these symptoms with the itching problems prior to the vaccine.  She did have a flat rash on her neck and arm, and when the doctor looked on it she was told that it was the start of shingles, but she had had the shingles vaccine a few weeks prior to that.  She was given Valacyclovir 10 mg. 3 times a day.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Lacrimation increased, Neck pain, Ocular hyperaemia, Pruritus, Rash
Clinical narrative: She got her vaccine, a few days later she started with redness in the white of her eyes, and they are still a little red and still watery.  She also had burning in her body and itching, and not feeling good.  The burning and itching was all over her body.  She did notifiy the doctor and went to see him, and went to the ER a few days after she saw her body as she could not get over the burning and itching and gave her a prescription for itching.  Her PCP did not say much and feels like she had an allergy to it.  She did not give her anything for her symptoms.  She got the itching pills from the ER.  She is still having the burning pain in her body.  She has a slight headache that she doesn't have to take anything for and checked her head for tumors and has an itchy scalp and a tad of a headache and pain in her neck and head.  She did not have these symptoms with the itching problems prior to the vaccine.  She did have a flat rash on her neck and arm, and when the doctor looked on it she was told that it was the start of shingles, but she had had the shingles vaccine a few weeks prior to that.  She was given Valacyclovir 10 mg. 3 times a day.
Age: 1.25
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Incorrect vaccine given. there was no harm to patient. The parent has been informed.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: TINNITUS
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 71.0
Sex: U
Vaccine: VARCEL
Symptoms: Feeling hot, Pruritus, Swelling
Clinical narrative: Swollen , hot, itchy skin with a lump for 8 days.
Age: 45.0
Sex: F
Vaccine: TD
Symptoms: Injection site pain, Pain in extremity, Vomiting
Clinical narrative: On 8/25/23 donor stated that her left arm was sore after receiving her tetanus immunization. Donor stated that she has had a sore arm for 9 days after receiving her first tetanus immunization.  Donor then stated that she vomited after receiving her first tetanus immunization on 04/14/23 and again after receiving her second immunization on 08/25/23 once she got home. Soreness in arm was localized to the injection site and donor did not seek any outside medical care after receiving both immunizations. There was no complaints of swelling, redness, itching, or anaphylaxis.  Donor's left arm was checked and there was no swelling, redness, or lump noted.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Headache, body aches, fever
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # FL3197 EXP:12/31/22 administered on 7/5/22 with beyond use date of 3/18/22 with recommendation to get booster
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # FL8095 administered on12/03/ 22 with beyond use date of 08/01/22 with recommendation to get booster at local pharmacy
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: vaccine administration error regarding Pfizer lot # GJ5342  administered on 02/08/2023 with beyond use date of 01/18/23 with recommendation to get booster at local pharmacy
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: vaccine administration error regarding Pfizer lot # GL0087 administered on 02/20/2023 with beyond use date of 02/17/2023 with recommendation to get booster at local pharmacy
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: vaccine administration error regarding Pfizer lot # GL0087  administered on 02/20/2023 with beyond use date of 02/17/2023 with recommendation to get booster at local pharmacy
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 22.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: vaccine administration error regarding Pfizer lot # GL0087  administered on 02/21/2023 with beyond use date of 02/17/2023 with recommendation to get booster at local pharmacy
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # GJ5342  administered on 03/21/2023 with beyond use date of 01/18/2023 with recommendation to get booster at local pharmacy
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 41.0
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # GJ5342  administered on 05/30/2023 with beyond use date of 01/18/2023 with recommendation to get booster at local pharmacy
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 18.0
Sex: M
Vaccine: TDAP
Symptoms: Electrocardiogram normal, Hypovolaemia, Syncope
Clinical narrative: This patient received Tdap and varicella on 1 Sep 23 as part of a mass vaccination line.  The patient had no immediate side effects.  The patient had syncope due to hypovolemia 4 hours later and was evaluated in the emergency room.
Age: 17.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # GJ5342   EXP: 12/31/2023 administered on 06/16/2023 with beyond use date of 01/18/2023 with recommendation to get booster at local pharmacy
Age: 47.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine administration error regarding Pfizer lot # GL0087 EXP: 02/29/2024 administered on 06/05/2023 with beyond use date of 02/17/2023 with recommendation to get booster at local pharmacy
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Cardiomyopathy
Clinical narrative: Patient is a 93 y.o. female patient of MD with PMH of COPD, CAD presented to the ED due to SOB and weakness. Treated for COPD/Covid.  Discharged to hospice care    Acute on chronic hypoxemic respiratory failure COPD Secondary to COVID pneumonia, COPD Required Bipap in ED, but was weaned down to NC. Home requirement is 2L Tachypnea slowly improved during admission  Pulm toilet Scheduled bronchodilators.   Covid-19 Virus Infection Date of onset of symptoms: 2 days(7/28/23) Symptoms present on admission: SOB, cough, weakness. Date of covid positive test: 7/30/23 Vaccination status: vaccinated Imaging: CXR no consolidation  Current oxygen requirements: 2L NC Medical therapy: steroids Anticipated special isolation end date: 8/8/23 CAD Non-ischemic cardiomyopathy LHC 7/10/23 with severe multi vessel disease, not amenable to PCI nor a surgical candidate, recommending medical management. EF 7/2023 EF 60%, pulm HTN 48 mmHg Resume home plavix, imdur, metoprolol, ranexa, statin.  Depression Lexapro   GERD Omeprazole, pepcid.     HTN Cozaar   Goals of Care Discussed code status, in agreement for DNRCCA-DNI Palliative consulted, family prefers home with hospice
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Catheterisation cardiac abnormal, Chest X-ray normal, Chronic obstructive pulmonary disease, Condition aggravated, Coronary artery disease
Clinical narrative: Patient is a 93 y.o. female patient of MD with PMH of COPD, CAD presented to the ED due to SOB and weakness. Treated for COPD/Covid.  Discharged to hospice care    Acute on chronic hypoxemic respiratory failure COPD Secondary to COVID pneumonia, COPD Required Bipap in ED, but was weaned down to NC. Home requirement is 2L Tachypnea slowly improved during admission  Pulm toilet Scheduled bronchodilators.   Covid-19 Virus Infection Date of onset of symptoms: 2 days(7/28/23) Symptoms present on admission: SOB, cough, weakness. Date of covid positive test: 7/30/23 Vaccination status: vaccinated Imaging: CXR no consolidation  Current oxygen requirements: 2L NC Medical therapy: steroids Anticipated special isolation end date: 8/8/23 CAD Non-ischemic cardiomyopathy LHC 7/10/23 with severe multi vessel disease, not amenable to PCI nor a surgical candidate, recommending medical management. EF 7/2023 EF 60%, pulm HTN 48 mmHg Resume home plavix, imdur, metoprolol, ranexa, statin.  Depression Lexapro   GERD Omeprazole, pepcid.     HTN Cozaar   Goals of Care Discussed code status, in agreement for DNRCCA-DNI Palliative consulted, family prefers home with hospice
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Depression, Dyspnoea, Ejection fraction normal, Gastrooesophageal reflux disease
Clinical narrative: Patient is a 93 y.o. female patient of MD with PMH of COPD, CAD presented to the ED due to SOB and weakness. Treated for COPD/Covid.  Discharged to hospice care    Acute on chronic hypoxemic respiratory failure COPD Secondary to COVID pneumonia, COPD Required Bipap in ED, but was weaned down to NC. Home requirement is 2L Tachypnea slowly improved during admission  Pulm toilet Scheduled bronchodilators.   Covid-19 Virus Infection Date of onset of symptoms: 2 days(7/28/23) Symptoms present on admission: SOB, cough, weakness. Date of covid positive test: 7/30/23 Vaccination status: vaccinated Imaging: CXR no consolidation  Current oxygen requirements: 2L NC Medical therapy: steroids Anticipated special isolation end date: 8/8/23 CAD Non-ischemic cardiomyopathy LHC 7/10/23 with severe multi vessel disease, not amenable to PCI nor a surgical candidate, recommending medical management. EF 7/2023 EF 60%, pulm HTN 48 mmHg Resume home plavix, imdur, metoprolol, ranexa, statin.  Depression Lexapro   GERD Omeprazole, pepcid.     HTN Cozaar   Goals of Care Discussed code status, in agreement for DNRCCA-DNI Palliative consulted, family prefers home with hospice
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Positive airway pressure therapy, Pulmonary hypertension, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 93 y.o. female patient of MD with PMH of COPD, CAD presented to the ED due to SOB and weakness. Treated for COPD/Covid.  Discharged to hospice care    Acute on chronic hypoxemic respiratory failure COPD Secondary to COVID pneumonia, COPD Required Bipap in ED, but was weaned down to NC. Home requirement is 2L Tachypnea slowly improved during admission  Pulm toilet Scheduled bronchodilators.   Covid-19 Virus Infection Date of onset of symptoms: 2 days(7/28/23) Symptoms present on admission: SOB, cough, weakness. Date of covid positive test: 7/30/23 Vaccination status: vaccinated Imaging: CXR no consolidation  Current oxygen requirements: 2L NC Medical therapy: steroids Anticipated special isolation end date: 8/8/23 CAD Non-ischemic cardiomyopathy LHC 7/10/23 with severe multi vessel disease, not amenable to PCI nor a surgical candidate, recommending medical management. EF 7/2023 EF 60%, pulm HTN 48 mmHg Resume home plavix, imdur, metoprolol, ranexa, statin.  Depression Lexapro   GERD Omeprazole, pepcid.     HTN Cozaar   Goals of Care Discussed code status, in agreement for DNRCCA-DNI Palliative consulted, family prefers home with hospice
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Tachypnoea
Clinical narrative: Patient is a 93 y.o. female patient of MD with PMH of COPD, CAD presented to the ED due to SOB and weakness. Treated for COPD/Covid.  Discharged to hospice care    Acute on chronic hypoxemic respiratory failure COPD Secondary to COVID pneumonia, COPD Required Bipap in ED, but was weaned down to NC. Home requirement is 2L Tachypnea slowly improved during admission  Pulm toilet Scheduled bronchodilators.   Covid-19 Virus Infection Date of onset of symptoms: 2 days(7/28/23) Symptoms present on admission: SOB, cough, weakness. Date of covid positive test: 7/30/23 Vaccination status: vaccinated Imaging: CXR no consolidation  Current oxygen requirements: 2L NC Medical therapy: steroids Anticipated special isolation end date: 8/8/23 CAD Non-ischemic cardiomyopathy LHC 7/10/23 with severe multi vessel disease, not amenable to PCI nor a surgical candidate, recommending medical management. EF 7/2023 EF 60%, pulm HTN 48 mmHg Resume home plavix, imdur, metoprolol, ranexa, statin.  Depression Lexapro   GERD Omeprazole, pepcid.     HTN Cozaar   Goals of Care Discussed code status, in agreement for DNRCCA-DNI Palliative consulted, family prefers home with hospice
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 76.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Pruritus, Skin warm
Clinical narrative: localized redness, hot to touch and itchu
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 92.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray normal
Clinical narrative: Patient is a 92 y.o. male with a history of dementia who recently left ED AMA on 7/29/23 s/p fall and found to have Right rib fractures who presented to hospital 8/9/2023 after fhe was found with confusion and weakness. On admit, COVID-19 positive with hypoxia.    1. Acute Toxic Metabolic Encephalopathy: possibly due to infection/COVID with baseline of dementia and hard of hearing. Improved with supportive care. 2. Acute Hypoxic Respiratory Failure: Secondary to viral pneumonia. Requiring 2-3 liters L O2 on admit; weaned off O2 8/11/23.  3. COVID-19 Pneumonia: Vaccinated. PCR positive on 8/9/23. CXR non-acute. Sepsis was ruled out. Continued on decadron and remdesivir through 8/14/23; no furhter decadron needed since he is not requiring oxygen. Isolation per protocol. 4. Diarrhea: 1 day prior to admit; resolved on 8/11/23.  5. Chronic Anemia: Baseline Hgb ~11. Stable on admit. 6. Dementia: really with age related memory loss; continued home meds  7. BPH: Continued home meds 8. Code status: DNR-CCA,DNI, confirmed with both POA, daughters
Age: 92.0
Sex: M
Vaccine: COVID19-2
Symptoms: Confusional state, Diarrhoea, Fall, Hypoxia, Pneumonia viral
Clinical narrative: Patient is a 92 y.o. male with a history of dementia who recently left ED AMA on 7/29/23 s/p fall and found to have Right rib fractures who presented to hospital 8/9/2023 after fhe was found with confusion and weakness. On admit, COVID-19 positive with hypoxia.    1. Acute Toxic Metabolic Encephalopathy: possibly due to infection/COVID with baseline of dementia and hard of hearing. Improved with supportive care. 2. Acute Hypoxic Respiratory Failure: Secondary to viral pneumonia. Requiring 2-3 liters L O2 on admit; weaned off O2 8/11/23.  3. COVID-19 Pneumonia: Vaccinated. PCR positive on 8/9/23. CXR non-acute. Sepsis was ruled out. Continued on decadron and remdesivir through 8/14/23; no furhter decadron needed since he is not requiring oxygen. Isolation per protocol. 4. Diarrhea: 1 day prior to admit; resolved on 8/11/23.  5. Chronic Anemia: Baseline Hgb ~11. Stable on admit. 6. Dementia: really with age related memory loss; continued home meds  7. BPH: Continued home meds 8. Code status: DNR-CCA,DNI, confirmed with both POA, daughters
Age: 92.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rib fracture, SARS-CoV-2 test positive, Toxic encephalopathy
Clinical narrative: Patient is a 92 y.o. male with a history of dementia who recently left ED AMA on 7/29/23 s/p fall and found to have Right rib fractures who presented to hospital 8/9/2023 after fhe was found with confusion and weakness. On admit, COVID-19 positive with hypoxia.    1. Acute Toxic Metabolic Encephalopathy: possibly due to infection/COVID with baseline of dementia and hard of hearing. Improved with supportive care. 2. Acute Hypoxic Respiratory Failure: Secondary to viral pneumonia. Requiring 2-3 liters L O2 on admit; weaned off O2 8/11/23.  3. COVID-19 Pneumonia: Vaccinated. PCR positive on 8/9/23. CXR non-acute. Sepsis was ruled out. Continued on decadron and remdesivir through 8/14/23; no furhter decadron needed since he is not requiring oxygen. Isolation per protocol. 4. Diarrhea: 1 day prior to admit; resolved on 8/11/23.  5. Chronic Anemia: Baseline Hgb ~11. Stable on admit. 6. Dementia: really with age related memory loss; continued home meds  7. BPH: Continued home meds 8. Code status: DNR-CCA,DNI, confirmed with both POA, daughters
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Clinical Summary Patient is a 66 year old  female with a history of COPD (baseline 4-5L NC), CAD (s/p CABG), chronic HFpEF, T2DM, HTN, and multiple recent admissions for COPD and CHF exacerbations last 7/28/23-8/2/23 for same. Patient represented to hospital on 8/9/23 with persistent SOB. Labs and imaging on admission: Cr 1.4, Trop 32, NT-Pro BNP 10k, WBC 11.9. CXR diffuse pulmonary edema with inflammatory changes possible pneumonitis. Patient found to have Covid-19.    1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis. 1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis and steroids. Continued decadron (end 8/18/23)  2. Acute on Chronic Respiratory Failure: Baseline uses 4-5L NC, stable on admission. CXR as discussed above. Suspect multifactorial in setting of Covid-19, acute CHF and underlying COPD. Continued treatment of underlying factors. Improved. Requiring 2-3L on discharge.  3. Acute on Chronic HFpEF: Follows with Heart Failure Clinic as an outpatient. Last TTE on 7/17/23 with RV slightly decreased dysfunction. NTProBNP on admission 10k. CXR with pulmonary edema. S/p IV Lasix, transitioned to PO Bumex last admit and HDMC followed at that time with increased bumex and added spironolactone on discharge. IV Lasix 20 on admit, and 8/10/23 with improvement. Continued home diuretics. 4. Remote COPD Exacerbation: Follows with outpatient pulm. S/p steroid, azithromycin last admission for exacerbation. No current AE on admit. Steroids as discussed. Continued home inhalers. Outpatient follow-up with pulmonologist. 5. Leukocytosis: Afebrile, WBC 11 on admit. Procal low risk. CXR without concern for pneumonia. Monitored.  6. CAD: per history, s/p CABG. Continued DAPT and statin.  7. CKD stage 3b: Baseline Cr 1.31.4. Admission Cr 1.40. Avoid nephrotoxic meds. Monitored.  8. NIDDM2: Last A1c 6.9 on 6/23/23. Held home orals. SSI on admit. Monitor and titrate PRN. 9. Generalized Psoriatic Rash: Follows with Dermatology as an outpatient. 10. HLD: per history. Continued statin. 11. Hypothyroidism: Continued Levothyroxine.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic kidney disease, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Clinical Summary Patient is a 66 year old  female with a history of COPD (baseline 4-5L NC), CAD (s/p CABG), chronic HFpEF, T2DM, HTN, and multiple recent admissions for COPD and CHF exacerbations last 7/28/23-8/2/23 for same. Patient represented to hospital on 8/9/23 with persistent SOB. Labs and imaging on admission: Cr 1.4, Trop 32, NT-Pro BNP 10k, WBC 11.9. CXR diffuse pulmonary edema with inflammatory changes possible pneumonitis. Patient found to have Covid-19.    1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis. 1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis and steroids. Continued decadron (end 8/18/23)  2. Acute on Chronic Respiratory Failure: Baseline uses 4-5L NC, stable on admission. CXR as discussed above. Suspect multifactorial in setting of Covid-19, acute CHF and underlying COPD. Continued treatment of underlying factors. Improved. Requiring 2-3L on discharge.  3. Acute on Chronic HFpEF: Follows with Heart Failure Clinic as an outpatient. Last TTE on 7/17/23 with RV slightly decreased dysfunction. NTProBNP on admission 10k. CXR with pulmonary edema. S/p IV Lasix, transitioned to PO Bumex last admit and HDMC followed at that time with increased bumex and added spironolactone on discharge. IV Lasix 20 on admit, and 8/10/23 with improvement. Continued home diuretics. 4. Remote COPD Exacerbation: Follows with outpatient pulm. S/p steroid, azithromycin last admission for exacerbation. No current AE on admit. Steroids as discussed. Continued home inhalers. Outpatient follow-up with pulmonologist. 5. Leukocytosis: Afebrile, WBC 11 on admit. Procal low risk. CXR without concern for pneumonia. Monitored.  6. CAD: per history, s/p CABG. Continued DAPT and statin.  7. CKD stage 3b: Baseline Cr 1.31.4. Admission Cr 1.40. Avoid nephrotoxic meds. Monitored.  8. NIDDM2: Last A1c 6.9 on 6/23/23. Held home orals. SSI on admit. Monitor and titrate PRN. 9. Generalized Psoriatic Rash: Follows with Dermatology as an outpatient. 10. HLD: per history. Continued statin. 11. Hypothyroidism: Continued Levothyroxine.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Hypothyroidism, Left ventricular failure, Leukocytosis, N-terminal prohormone brain natriuretic peptide increased
Clinical narrative: Clinical Summary Patient is a 66 year old  female with a history of COPD (baseline 4-5L NC), CAD (s/p CABG), chronic HFpEF, T2DM, HTN, and multiple recent admissions for COPD and CHF exacerbations last 7/28/23-8/2/23 for same. Patient represented to hospital on 8/9/23 with persistent SOB. Labs and imaging on admission: Cr 1.4, Trop 32, NT-Pro BNP 10k, WBC 11.9. CXR diffuse pulmonary edema with inflammatory changes possible pneumonitis. Patient found to have Covid-19.    1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis. 1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis and steroids. Continued decadron (end 8/18/23)  2. Acute on Chronic Respiratory Failure: Baseline uses 4-5L NC, stable on admission. CXR as discussed above. Suspect multifactorial in setting of Covid-19, acute CHF and underlying COPD. Continued treatment of underlying factors. Improved. Requiring 2-3L on discharge.  3. Acute on Chronic HFpEF: Follows with Heart Failure Clinic as an outpatient. Last TTE on 7/17/23 with RV slightly decreased dysfunction. NTProBNP on admission 10k. CXR with pulmonary edema. S/p IV Lasix, transitioned to PO Bumex last admit and HDMC followed at that time with increased bumex and added spironolactone on discharge. IV Lasix 20 on admit, and 8/10/23 with improvement. Continued home diuretics. 4. Remote COPD Exacerbation: Follows with outpatient pulm. S/p steroid, azithromycin last admission for exacerbation. No current AE on admit. Steroids as discussed. Continued home inhalers. Outpatient follow-up with pulmonologist. 5. Leukocytosis: Afebrile, WBC 11 on admit. Procal low risk. CXR without concern for pneumonia. Monitored.  6. CAD: per history, s/p CABG. Continued DAPT and statin.  7. CKD stage 3b: Baseline Cr 1.31.4. Admission Cr 1.40. Avoid nephrotoxic meds. Monitored.  8. NIDDM2: Last A1c 6.9 on 6/23/23. Held home orals. SSI on admit. Monitor and titrate PRN. 9. Generalized Psoriatic Rash: Follows with Dermatology as an outpatient. 10. HLD: per history. Continued statin. 11. Hypothyroidism: Continued Levothyroxine.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonitis, Psoriasis, Pulmonary oedema, Right ventricular dysfunction, Sputum discoloured
Clinical narrative: Clinical Summary Patient is a 66 year old  female with a history of COPD (baseline 4-5L NC), CAD (s/p CABG), chronic HFpEF, T2DM, HTN, and multiple recent admissions for COPD and CHF exacerbations last 7/28/23-8/2/23 for same. Patient represented to hospital on 8/9/23 with persistent SOB. Labs and imaging on admission: Cr 1.4, Trop 32, NT-Pro BNP 10k, WBC 11.9. CXR diffuse pulmonary edema with inflammatory changes possible pneumonitis. Patient found to have Covid-19.    1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis. 1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis and steroids. Continued decadron (end 8/18/23)  2. Acute on Chronic Respiratory Failure: Baseline uses 4-5L NC, stable on admission. CXR as discussed above. Suspect multifactorial in setting of Covid-19, acute CHF and underlying COPD. Continued treatment of underlying factors. Improved. Requiring 2-3L on discharge.  3. Acute on Chronic HFpEF: Follows with Heart Failure Clinic as an outpatient. Last TTE on 7/17/23 with RV slightly decreased dysfunction. NTProBNP on admission 10k. CXR with pulmonary edema. S/p IV Lasix, transitioned to PO Bumex last admit and HDMC followed at that time with increased bumex and added spironolactone on discharge. IV Lasix 20 on admit, and 8/10/23 with improvement. Continued home diuretics. 4. Remote COPD Exacerbation: Follows with outpatient pulm. S/p steroid, azithromycin last admission for exacerbation. No current AE on admit. Steroids as discussed. Continued home inhalers. Outpatient follow-up with pulmonologist. 5. Leukocytosis: Afebrile, WBC 11 on admit. Procal low risk. CXR without concern for pneumonia. Monitored.  6. CAD: per history, s/p CABG. Continued DAPT and statin.  7. CKD stage 3b: Baseline Cr 1.31.4. Admission Cr 1.40. Avoid nephrotoxic meds. Monitored.  8. NIDDM2: Last A1c 6.9 on 6/23/23. Held home orals. SSI on admit. Monitor and titrate PRN. 9. Generalized Psoriatic Rash: Follows with Dermatology as an outpatient. 10. HLD: per history. Continued statin. 11. Hypothyroidism: Continued Levothyroxine.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin, Type 2 diabetes mellitus, White blood cell count increased
Clinical narrative: Clinical Summary Patient is a 66 year old  female with a history of COPD (baseline 4-5L NC), CAD (s/p CABG), chronic HFpEF, T2DM, HTN, and multiple recent admissions for COPD and CHF exacerbations last 7/28/23-8/2/23 for same. Patient represented to hospital on 8/9/23 with persistent SOB. Labs and imaging on admission: Cr 1.4, Trop 32, NT-Pro BNP 10k, WBC 11.9. CXR diffuse pulmonary edema with inflammatory changes possible pneumonitis. Patient found to have Covid-19.    1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis. 1. Covid-19: pt endorsed worsening SOB and cough with green sputum 3-4 days PTA. Covid-19 on admission. Vaccinated. CXR on admit with diffuse pulmonary edema with inflammatory changes possible pneumonitis. Improved with pulmonary hygiene, diuresis and steroids. Continued decadron (end 8/18/23)  2. Acute on Chronic Respiratory Failure: Baseline uses 4-5L NC, stable on admission. CXR as discussed above. Suspect multifactorial in setting of Covid-19, acute CHF and underlying COPD. Continued treatment of underlying factors. Improved. Requiring 2-3L on discharge.  3. Acute on Chronic HFpEF: Follows with Heart Failure Clinic as an outpatient. Last TTE on 7/17/23 with RV slightly decreased dysfunction. NTProBNP on admission 10k. CXR with pulmonary edema. S/p IV Lasix, transitioned to PO Bumex last admit and HDMC followed at that time with increased bumex and added spironolactone on discharge. IV Lasix 20 on admit, and 8/10/23 with improvement. Continued home diuretics. 4. Remote COPD Exacerbation: Follows with outpatient pulm. S/p steroid, azithromycin last admission for exacerbation. No current AE on admit. Steroids as discussed. Continued home inhalers. Outpatient follow-up with pulmonologist. 5. Leukocytosis: Afebrile, WBC 11 on admit. Procal low risk. CXR without concern for pneumonia. Monitored.  6. CAD: per history, s/p CABG. Continued DAPT and statin.  7. CKD stage 3b: Baseline Cr 1.31.4. Admission Cr 1.40. Avoid nephrotoxic meds. Monitored.  8. NIDDM2: Last A1c 6.9 on 6/23/23. Held home orals. SSI on admit. Monitor and titrate PRN. 9. Generalized Psoriatic Rash: Follows with Dermatology as an outpatient. 10. HLD: per history. Continued statin. 11. Hypothyroidism: Continued Levothyroxine.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 66.0
Sex: F
Vaccine: RSV
Symptoms: Blood glucose increased, Illness
Clinical narrative: I don't know which type of RSV vaccine type I got.  I was ill from the high blood sugar
Age: 16.0
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event. Hib was given to 16 y.o. (outside of age recommendation) in error.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Dizziness, Electrocardiogram normal, Sinus rhythm, Syncope
Clinical narrative: Mother reports around 410 patient was going upstairs while feeling feels dizzy. Patient reports lowering herself to the ground and then recalls waking up.  Went to ED 17 year old female presents to ED for syncopal event. Upon initial assessment, Pt. Alert, NAD, non toxic appearing. Interactive, answering questions appropriately. Gait steady. Balane intact. Strength equal bilaterally. Head atraumatic. PERRL. EOM intact. Vision and hearing intact. VSS. RR even and unlabored. LSCTA. Skin PWD. MMM. Abd. Soft, non distneded. Non tender. Orthostatic VS unremarkable. EKG NSR. Discussed possible adverse effect r/t vaccine vs. Syncope r/t change of position quickly. Upon reassessment, pt. Remained in NAD, RR even and unlabored, VSS, tolerating PO. Pat. And mother agreeable to discharge
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Unevaluable event
Clinical narrative: patient is age appropriate for this vaccine  and patient did not have any reaction to this vaccine. Patient is 17 year 11 month old and standing order age limit is 18 year so thats what filling out VARES. pts is ok and no harm
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: After the second Shingrix dose, I developed a  fever about 12 hours post-injection, and slept very poorly that night.   The following morning, at 22 hours post-injection, I woke up with significant upper-body muscle and joint aches, and fatigue.    I was not expecting this severe a reaction, since I had no reaction at all to the first dose.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Bedridden, Blood test, Brain fog
Clinical narrative: I have had heart palpations, lethargic, headaches constantly,dizziness, constant no energy- bedridden,muscle soreness, balance issues, brain fog, and major fatigue. Still to this day, 2 yrs later.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac ablation, Dizziness, Electrocardiogram, Fatigue, Headache
Clinical narrative: I have had heart palpations, lethargic, headaches constantly,dizziness, constant no energy- bedridden,muscle soreness, balance issues, brain fog, and major fatigue. Still to this day, 2 yrs later.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lethargy, Myalgia, Palpitations, Scan brain
Clinical narrative: I have had heart palpations, lethargic, headaches constantly,dizziness, constant no energy- bedridden,muscle soreness, balance issues, brain fog, and major fatigue. Still to this day, 2 yrs later.
Age: 36.0
Sex: F
Vaccine: HPV9
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: patient was given vaccine and within 2 min of administration pt. started to have chest tightness and unable able to talk or breath and grabbing her throat. Orders to give 1 dose of epi pen 0.3mg given to her left thigh and oxygen given @ 2 liters. EMS was activated. Patient was taken by EMS.
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event reported.  Patient was given a second bivalent booster when he was not due for it.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Uveitis
Clinical narrative: I was 8 weeks pregnant and lost the baby. I also got uveitis. I took the Phizer vacine
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL, DTAPIPV, MMR, VARCEL
Symptoms: Cough, Pharyngeal swelling, Rash macular, Sneezing
Clinical narrative: Pt. sneezing, red blotchy face and chest, cough, throat swelling  Gave pt. Benadryl PO, Gave Dexamethazone IM,  breathing treatment  Monitored -congestion resolved, rash resolved. O2 100%  HR 122  RR 22
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL, DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Rash macular, Sneezing
Clinical narrative: Pt. sneezing, red blotchy face and chest, cough, throat swelling  Gave pt. Benadryl PO, Gave Dexamethazone IM,  breathing treatment  Monitored -congestion resolved, rash resolved. O2 100%  HR 122  RR 22
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: There were no adverse side effects, and patients mother was spoken to over the phone and has agreed to the vaccine that was given, and mother is not upset.
Age: 32.0
Sex: F
Vaccine: HPV9
Symptoms: Oropharyngeal pain, Throat tightness
Clinical narrative: At check out pt c/o sore throat and feeling closing/tightness to throat. Provider called to eval pt. BP 136/89, P-82, SPo2 98%. @13:53 Solumedrol 125 mg single dose given IM to L buttock. Epi pen 0.3mg to L thigh, Benadryl 50mg/ml IM given to R deltoid- all orders from NP received. EMS called,
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Expired product administered
Clinical narrative: Vaccine given on 9/7/2023, but vaccine expired on 8/31/2023